Objective. To determine the efficacy, safety and immunogenicity of the heptavalent CRM 197
pneumococcal conjugate vaccine against invasive disease caused by vaccine serotypes …

A correlate of protection (CoP) is urgently needed to expedite development of additional
COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody titers …

Background Ear infections are a common cause of illness during the first two years of life.
New conjugate vaccines may be able to prevent a substantial portion of cases of acute otitis …

We analyzed >70 recent data sets to compare the serogroups causing invasive pneumococcal
disease (IPD) with those represented in conjugate vaccine formulations. Five to 8 and 10–…

Background Infants with cardiac disease or prematurity are at risk for severe illness caused
by respiratory syncytial virus. Immune globulin with a high titer of antibodies against …

Objective. —To determine whether long-term supplementation with vitamin E enhances in
vivo, clinically relevant measures of cell-mediated immunity in healthy elderly subjects. Design…

Adjuvants help antigen to elicit an early, high and long-lasting immune response with less
antigen, thus saving on vaccine production costs. In recent years, adjuvants received much …

We measured serum concentrations of immunoglobulin classes and IgG subclasses in 53
patients who had completed treatment for Hodgkin's disease and in 10 healthy adults. We …

The World Health Organization (WHO) is undertaking a series of consultations on serological
criteria for the evaluation and licensure of new formulations/combinations or different …

Background Streptococcus pneumoniae is the main cause of invasive bacterial disease in
children aged younger than 2 years. Navajo and White Mountain Apache children have some …